Trinity Biotech PLC reports results for the quarter ended September 30 - Earnings Summary

Trinity Biotech

15/11/2024 14:31

* Trinity Biotech PLC  TRIB.OQ  reported a quarterly
adjusted loss
of 46 cents​​ per share for the quarter ended September 30.  The
lone analyst forecast for the quarter was for a loss of 54 cents
per share. 
    * Revenue rose 3.2% to $15.15 million from a year ago;
analysts
expected $16.50 million. 
    * Trinity Biotech PLC's reported EPS for the quarter was a
loss
of 46 cents​.
    * Trinity Biotech PLC shares had risen by 34.5% this
quarter and
lost 31.0% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 1.8%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * 

This summary was machine generated from LSEG data November 15 at
02:31 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.54          -0.46          Beat
 Jun. 30 2024      -0.65          -0.71          Missed